The Phosphatase Inhibitor LB-100 Creates Neoantigens in Colon Cancer Cells Through Perturbation of mRNA Splicing

Scientists reported a sensitivity of the mRNA splicing machinery to phosphorylation changes in response to LB-100 in colorectal adenocarcinoma.